- We will send in 10–14 business days.
/images/books/3335981/9780367261177.jpg)
- Publisher: CRC Press
- ISBN-10: 0367261170
- ISBN-13: 9780367261177
- Format: 15.6 x 23.4 x 2.4 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Cancer Clinical Trials (e-book) (used book) | bookbook.eu
Reviews
Description
Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials.
The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 18d.07:54:15
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: CRC Press
- ISBN-10: 0367261170
- ISBN-13: 9780367261177
- Format: 15.6 x 23.4 x 2.4 cm, softcover
- Language: English English
Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials.
The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.
Reviews